Shenzhen Kangzhe Biotechnology Co., Ltd.
3 clinical trials · Sponsor
◉ Watch Shenzhen Kangzhe Biotechnology Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Phase 1 Study of Ascending Doses of CMS-D008 in Healthy and Overweight/Obese Adults (NCT07518589) | Shenzhen Kangzhe Biotechnology Co., Ltd. | 2026-04-02 |
| A Phase I Clinical Trial to Evaluate CMS-D017 Following Single and Multiple Doses in Healthy Participants (NCT07462780) | Shenzhen Kangzhe Biotechnology Co., Ltd. | 2026-03-05 |
| Phase II Study of CMS-D002 Capsule for Uterine Fibroids With Menorrhagia (NCT07402369) | Shenzhen Kangzhe Biotechnology Co., Ltd. | 2026-02-19 |
Track Shenzhen Kangzhe Biotechnology Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.